Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LIZTOX in Post Stroke Upper Limb Spasticity
NCT05289921Phase 3Completed
- Sponsor
- Huons
- Start
- Mar 2022
- Primary completion
- Jan 2023
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Bacterial Toxin Conjugates
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of hutox in spasticity (2 arms), sponsored by Huons. Primary endpoint: Modified Ashworth Scale score improvement at Wrist Flexor at 4 weeks. Started Mar 2022; status: completed.
02
Drugs
hutox
03
Conditions
spasticity
Beyond the preview
Go deeper on NCT05289921.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05289921.